Elsevier

Clinics in Liver Disease

Volume 6, Issue 3, August 2002, Pages 727-737
Clinics in Liver Disease

Pathogenesis of autoimmune hepatitis

https://doi.org/10.1016/S1089-3261(02)00018-1Get rights and content

Section snippets

Cellular immunity

Examination of the liver tissue reveals a dramatic picture. A multitude of mononuclear cells, lymphocytes, plasma cells, and macrophages infiltrate the portal tract, invade the adjacent parenchyma, and surround dying hepatocytes. This scenario, defined by histologists as interface hepatitis, first suggested that autoaggressive cellular immunity was involved in the pathogenesis of the disease [1], [2]. Immunocytochemical studies have identified the phenotype of the infiltrating cells. T

Humoral immunity and T and B Cell Co-operation

Titers of antibodies to the liver specific lipoprotein (LSP), a macromolecular complex present on the hepatocyte membrane, and to its well-characterized component, asialoglycoprotein receptor (ASGPR), correlate with the biochemical and histologic severity of AIH [16], [17]. Recently, antibodies to alcohol dehydrogenase (ADH), a second well-defined component of LSP, have been described in patients with AIH [18]. Immunofluorescence studies on monodispersed suspensions of liver cells obtained from

Possible routes to autoimmunity

The immune system has evolved to discriminate between endogenous or self tissues and exogenous and neoplastic components, collectively termed nonself. A dominant selective pressure in this process has been the threat to self-integrity posed by infectious pathogens. The virtually infinite antigenic variety of pathogens to which the immune system must respond has resulted in an innate set of responses that allow the triggering of immunity to commonly encountered pathogens. An adaptive system has

Antibodies to liver and kidney microsome type 1 and molecular mimicry

Type 2 AIH is characterized by seropositivity for antibodies to liver and kidney microsome type 1 (anti-LKM1) [35]. The target of this reactivity is cytochrome P450 2D6 (CYP2D6)—a member of the hepatic P450 enzyme family [36]. Because of the strong association between anti-LKM1 and type 2 AIH and because of a recent report showing surface expression of CYP2D6 on hepatocytes (rendering them amenable to recognition by these antibodies), anti-LKM1 are thought to be involved in the pathogenesis of

Multiple autoimmunity in autoimmune hepatitis

Type 2 AIH frequently coexists with other autoimmune diseases, particularly type 1 diabetes, Addison's disease, hypoparathyroidism, and autoimmune thyroiditis [47]. The authors have shown cross-reactive anti-LKM1 responses among CYP2D6321-351, the second most frequently recognized epitope of CYP2D6, and structurally similar regions of carboxypeptidase H, an autoantigen in type 1 diabetes, and 21-hydroxylase, the major autoantigen in Addison's disease [48]. The authors propose that autoimmunity

Summary

Autoimmune hepatitis is initiated by CD4 T cells that recognize self-antigen. The effector cells differentiate into functional phenotypes according to cytokines in the microenvironment and the nature of the triggering antigen. Hepatocytes can express class II molecules and present antigenic peptides through a bystander mechanism. NKT cells reside in the normal liver but may be involved in liver cell damage possibly through the expression of Fas ligand. Autoantibodies may also participate in the

First page preview

First page preview
Click to open first page preview

References (50)

  • P. Scheuer

    Chronic aggressive hepatitis

  • G. Senaldi et al.

    Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis

    Arch Dis Child

    (1992)
  • T. Abo et al.

    Physiological responses of extrathymic T cells in the liver

    Immunol Rev

    (2000)
  • K. Takeda et al.

    Critical contribution of liver natural killer T cells to a murine model of hepatitis

    Proc Natl Acad Sci USA

    (2000)
  • K.T. Nouri-Aria et al.

    T suppressor cell function and number in children with liver disease

    Clin Exp Immunol

    (1985)
  • P.T. Donaldson et al.

    Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

    Hepatology

    (1991)
  • K.T. Nouri-Aria et al.

    Effect of corticosteroids on suppressor-cell activity in “autoimmune” and viral chronic active hepatitis

    N Engl J Med

    (1982)
  • A. Lobo-Yeo et al.

    Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease

    Hepatology

    (1990)
  • M. Chen et al.

    Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells

    J Virol

    (1998)
  • A. Lobo-Yeo et al.

    Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis

    Clin Exp Immunol

    (1987)
  • A.J. Czaja et al.

    Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

    Immunol Rev.

    (2000)
  • D.M. Jensen et al.

    Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis

    N Engl J Med

    (1978)
  • D. Vergani et al.

    Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage

    Liver

    (1987)
  • G. Mieli-Vergani et al.

    Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis

    Clin Exp Immunol

    (1979)
  • L. Wen et al.

    Paediatric autoimmune liver disease: the molecular basis of humoral and cellular immunity

    Curr Mol Med

    (2001)
  • Cited by (0)

    View full text